Navigation Links
China-Biotics Files New Patent Applications
Date:9/16/2010

t may be deemed to be forward-looking statements, which may be identified by terminology such as "may," "should," "will," "expect," "plan," "intend," "anticipate," "believe," "estimate," "predict," "potential," "forecast," "project," "continue," or the negative of such terms or other comparable terminology. Readers should not rely on forward-looking statements as predictions of future events or results. Any or all of the Company's forward-looking statements may turn out to be wrong. They can be affected by inaccurate assumptions, risks and uncertainties and other factors which could cause actual events or results to be materially different from those expressed or implied in the forward-looking statements. In evaluating these statements, readers should consider various factors, including the risks described in "Item 1A. Risk Factors" beginning on page 17 and elsewhere in the Company's 2010 Annual Report on Form 10-K. These factors may cause the Company's actual results to differ materially from any forward-looking statement. In addition, new factors emerge from time to time and it is not possible for the Company to predict all factors that may cause actual results to differ materially from those contained in any forward-looking statements. The Company disclaims any obligation to publicly update any forward-looking statements to reflect events or circumstances after the date of this document, except as required by applicable law.

For more information, please contact: China-Biotics, Inc. Travis Cai Chief Financial Officer Email: traviscai@chn-biotics.com Grayling Kevin Theiss / Shiwei Yin Tel: +1-646-284-9409 Email: kevin.theiss@grayling. com shiwei.yin@grayling.com
'/>"/>

SOURCE China-Biotics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. China-Biotics, Inc. Comments on Market Rumors
2. China-Biotics Announces September 20 Investor Day Schedule
3. China-Biotics to Host Investor Day in Shanghai to Discuss Corporate Development Strategy
4. China-Biotics, Inc. Announces US$20 million Share Buyback Program
5. China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010
6. China-Biotics, Inc. Begins Trial Production at New Facility, Affirms 2010 Revenue Guidance
7. China-Biotics, Inc. Prices $69 Million Public Offering of Common Stock
8. Medizone International Files For Additional Bio-Terrorism Countermeasures Patent Protection
9. Horizon Pharma, Inc. Files Registration Statement for Proposed Initial Public Offering
10. Concord Medical Files 2009 Annual Report on Form 20-F
11. Tongjitang Files 2009 Annual Report on Form 20-F
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... 18, 2014  Decision Resources Group finds that ... United States , 54 percent of surveyed ... Tafinlar for BRAF -mutation-positive unresectable or metastatic ... GlaxoSmithKline,s MEK inhibitor Mekinist. Among current non-prescribers of ... and 43 percent, respectively) expects to prescribe these ...
(Date:9/18/2014)... 2014  Iliad Neurosciences, Inc., a company focused on ... Autism Spectrum Disorders (ASD) announced today that it has ... Foundation for The State University of New York. ... biomarker to identify an abnormality in folate transport to ... is expected to be available for research use by ...
(Date:9/18/2014)... Mass. , Sept. 18, 2014  Decision Resources ... anti-vascular endothelial growth factor (VEGF) agent for wet AMD, ... Medicare Advantage plans as Genentech,s Lucentis, which is the ... surveyed managed care organization (MCO) directors do not identify ... is slightly more likely than Lucentis to be listed ...
Breaking Medicine Technology:At One Year Post-Launch, Approximately One Half of Surveyed U.S. Medical Oncologists Have Prescribed Single-Agent Tafinlar and Mekinist to Their Malignant Melanoma Patients 2Iliad Neurosciences, Inc. enters into an Exclusive License Agreement with The Research Foundation for The State University of New York 2Iliad Neurosciences, Inc. enters into an Exclusive License Agreement with The Research Foundation for The State University of New York 3Regeneron's Eylea and Genentech's Lucentis Are Equally Likely to be Covered on Commercial and Medicare Advantage Plans for Wet AMD 2Regeneron's Eylea and Genentech's Lucentis Are Equally Likely to be Covered on Commercial and Medicare Advantage Plans for Wet AMD 3
... -- China Sky One Medical, Inc. ("China Sky One" or ... integrated pharmaceutical company producing over-the-counter drugs in the People,s Republic ... quarter and fiscal year ended December 31, 2010. ... Highlights Total revenues decreased by $3.0 million, ...
... Saffron Technology, Inc. , a privately-held data analytics ... and government, today announced the addition of four ... .   "Our Executive Advisors possess ... broad knowledge of industries and markets important to ...
Cached Medicine Technology:China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 2China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 3China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 4China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 5China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 6China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 7China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 8China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 9China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 10China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 11China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 12China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 13China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 14Saffron Technology Adds Seasoned Business Executives to Advisory Board 2Saffron Technology Adds Seasoned Business Executives to Advisory Board 3
(Date:9/18/2014)... Savannah, GA (PRWEB) September 18, 2014 ... awarded the Alex Ormond, Jr. Leadership Award by the ... toward improving healthcare and wellness throughout the nation and ... to receive this award,” said Ben. “The Savannah Science ... for 65 years and multiple generations have gone through ...
(Date:9/18/2014)... will convene a one-day conference at the Milken Institute ... on September 25, 2014 to discuss the Global Health ... The purpose of this event is to invite discussion ... five years, including action plans to curtail the current ... the GHSA, international organizations and more than 50 countries ...
(Date:9/18/2014)... the Ebola virus invoke scary scenarios of deadly epidemics, ... are still providing researchers with new insights on how ... published online Sept. 18, 2014, in the journal ... Medical School Singapore detail how the Yersinia pestis bacteria ... the lymph nodes and eventually ride into the lungs ...
(Date:9/18/2014)... 18, 2014 As testosterone treatment ... U.S. courts, Bernstein Liebhard LLP notes that a ... Food & Drug Administration (FDA) subject prescription low ... could greatly reduce their use. The joint meeting ... Advisory Committee, and the Drug Safety and Risk ...
(Date:9/18/2014)... Once again, Hickman’s Family Farms will partner with ... to celebrate PJs & Eggs. The sixth annual event ... 10, 2014. The “breakfast for dinner” will begin at ... Association (AzCA) foster care programs statewide. , Customers ... on October 10 are invited to wear their pajamas ...
Breaking Medicine News(10 mins):Health News:Quirk Awarded the Alex Ormond, Jr. Leadership Award by the Savannah Science Seminar 2Health News:Non-governmental stakeholders to discuss the Global Health Security Agenda 2Health News:New insights on an ancient plague could improve treatments for infections 2Health News:Testosterone Treatment News: Bernstein Liebhard LLP Notes Experts’ Recommendations for New Restrictions on Low Testosterone Therapy 2Health News:Testosterone Treatment News: Bernstein Liebhard LLP Notes Experts’ Recommendations for New Restrictions on Low Testosterone Therapy 3Health News:Testosterone Treatment News: Bernstein Liebhard LLP Notes Experts’ Recommendations for New Restrictions on Low Testosterone Therapy 4Health News:October 10th Is 6th Annual PJs & Eggs: Hickman’s Family Farms and Breakfast Restaurants Partner to Benefit Arizona Foster Children 2
... Mann HealthDay Reporter , THURSDAY, Feb. 16 (HealthDay ... be a hidden source of arsenic, new research suggests. ... brown rice syrup, is found in some infant formulas. Their ... Health Perspectives . Arsenic is a natural element that ...
... delivery directly into muscle using an autoinjector is faster ... according to a study sponsored by the National Institutes ... School of Medicine researcher. The trial compared the ... how they are administered to patients suffering prolonged seizures ...
... , THURSDAY, Feb. 16 (HealthDay News) -- Doing ... that all Americans must have health insurance would not ... insurance exchanges, but would significantly reduce the number of ... findings from the RAND Corporation, a nonprofit research organization, ...
... Mann HealthDay Reporter , WEDNESDAY, Feb. 15 ... help problem drinkers cut their alcohol consumption, a small ... curbs drinking is not fully understood, but its use ... sadness and nausea, thereby blunting the pleasurable effects of ...
... Reporter , WEDNESDAY, Feb. 15 (HealthDay News) -- Researchers report ... kicking off puberty in humans, a finding that offers insight ... who suffer from a rare disease that prevents the start ... family whose members have suffered from the disease confirmed that ...
... Feb. 15 (HealthDay News) -- How fast you walk or how ... odds for dementia or stroke later in life, a new study ... performed in a doctor,s office, noted study author Dr. Erica C. ... tested the walking speed, hand grip strength and cognitive function of ...
Cached Medicine News:Health News:Arsenic Might Be Found in Some Organic Foods: Study 2Health News:Arsenic Might Be Found in Some Organic Foods: Study 3Health News:Wayne State research reveals improved method for paramedics to stop prolonged seizures 2Health News:Wayne State research reveals improved method for paramedics to stop prolonged seizures 3Health News:Wayne State research reveals improved method for paramedics to stop prolonged seizures 4Health News:Health Insurance 'Mandate' Deemed Best Value for Money 2Health News:Stop-Smoking Drug May Also Curb Problem Drinking 2Health News:Gene Linked to Start of Puberty 2Health News:Can Walking Speed, Hand Grip in Middle Age Predict Dementia Risk? 2
Polygraf ID Adapter Cable for LATITUDE® Air-Charged Catheter...
Solid State Manometry Catheter Accessory., ,Manometric calibrators are required for calibration of solid state catheters., ,Each type of catheter requires a unique calibrator....
Sphincter of Oddi Solid State Catheter Adapter Cable for Polygraf ID...
... The ITREL 3 is a battery ... in the U.S., ,Enterra™ Therapy is ... and vomiting associated with gastroparesis when conventional ... of symptons for diabetic or idiopathic patients., ...
Medicine Products: